Among them, VSIG4, SIGLEC1, and CXCL13 were significantly positively correlated with estimate scores, stromal scores, and immune scores in pan-cancer, while negatively correlated with tumor purity (Supplementary Figure 9). This evidence concerns the gene CXCL13 and cancer.